Welcome to the June 23, 2017, issue of Pharma Industry News Update (aka PinUp). This issue of PinUp focuses on the credibility of health information on the Web in general and specifically communications from pharma companies via blogs and press releases.
Welcome to the August 22, 2017, issue of Pharma Industry News Update (aka PinUp). Pharma industry spending on direct-to-consumer (DTC) advertising is at record levels. The big money is going to big media magazines while online health sites are struggling to compete. Meanwhile, FDA is seems to be seeking evidence to limit the amount of risk information in TV ads. Enough studies already!, says PhRMA in what may be an ill-timed critique.
Welcome to the September 6, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.
PinUp: Dr. Scott Gottlieb Answers Questions About Drug Safety, Speeding FDA’s Drug Approval Process,...
Welcome to the April 7, 2017, issue of Pharma Industry News Update (aka PinUp). Where's the balance between drug safety and speeding up clinical trials to bring drugs to market faster? That was a major issue underscoring the testimony of Dr. Scott Gottlieb, president Trump's nominee to head the FDA, before the U.S. Senate Committee on Health, Education, Labor and Pensions.
So-called immunotherapy drugs have been hailed as a breakthrough in cancer treatment, attracting billions of research dollars and offering new hope to patients out of options. But as their...
Trying to determine what portion of pharma's total marketing budget is devoted to digital and if that portion is increasing, is a daunting task.
Welcome to the December 5, 2017, issue of Pharma Industry News Update (aka PinUp). I just downloaded Apple's
Welcome to the July 14, 2017, issue of Pharma Industry News Update (aka PinUp). It's time to see which pharma executives received the most compensation in 2016, even if a large chunk depends on stock price! We're talking tens of millions of dollars here! I am totally surprised that Pfizer's CEO and Chairman Ian Read 'took home' so much less than 'price gouging' Mylan and Valeant executives. Go figure!
This article documents the concerns about the risks of drug sales reps as well as the benefits to physicians.
Welcome to the August 1, 2017, issue of Pharma Industry News Update (aka PinUp). Pharma scientists may be concerned about the portrayal of biopharma scientists as crazed villains in Hollywood movies, but they should be more concerned - mad as hell - about clinical and other data being hacked especially since their IT people should have been more on the ball!